Rule 24.174.1501 - PARTICIPATION AND REGISTRATION(1) A pharmacy or facility may fully participate in the cancer drug repository program by accepting, storing and dispensing, or administering donated drugs and supplies, or may limit its participation to only accepting and storing donated drugs and supplies. If a pharmacy or facility chooses to limit its participation, the pharmacy or facility shall distribute any donated drugs to a fully participating repository.(2) Any patient who is diagnosed with cancer is eligible to receive drugs or supplies under the cancer drug repository program.(3) The program is voluntary, and any pharmacy or facility must notify the board of their interest in participating in the program.(4) There is no limitation on the number of doses that can be donated to the program as long as the donated drugs meet the requirements of these regulations.(5) Any person or entity (donor) may donate cancer drugs to the program. The donor must contact a pharmacy or facility to obtain a form on which the donor must specify the drug(s) to be donated. The board will supply the form to be used which will include the provisions of 37-7-1405, MCA, and the: (a) name and quantity of the drug; and(b) name of the person the drug was originally prescribed, their relationship with the donor, the signature of the donor, and the date the form was signed.(6) The board may inspect a pharmacy or facility participating in the program for compliance with the storage and record-keeping requirements. The board may terminate participation in the program for noncompliance.(7) The board shall establish and maintain a list of any pharmacy or facility participating in the program by issuing an endorsement on the license at no cost. The endorsement application information must include the entity's name, address, telephone number, and if it is a practitioner's office, pharmacy, clinic, or hospital, in compliance with 37-7-1403, MCA. The pharmacy or facility must notify the board of any changes to their registration information, including when they stop participating in the program.(8) The board will make the pharmacy or facility registry information available to any person or entity wishing to donate cancer drugs to the program, and will make the information available on the board webpage or by contacting the board office.Mont. Admin. r. 24.174.1501
NEW, 2010 MAR p. 2968, Eff. 12/24/10; AMD, 2024 MAR p. 2219, Eff. 9/21/2024AUTH: 37-7-1401, MCA; IMP: 37-7-1401, 37-7-1403, 37-7-1405, MCA